Cathie Wood acquired 24.6 Million Recursion Pharmaceuticals shares worth $193 Million. That's 1.55% of their equity portfolio (17th largest holding). The investor owns 11.55% of the outstanding Recursion Pharmaceuticals stock. The first Recursion Pharmaceuticals trade was made in Q2 2021. Since then Cathie Wood bought shares eight more times and sold shares on three occasions. The investor's estimated purchase price is $257 Million, resulting in a loss of 25%.
Recursion Pharmaceuticals (NASDAQ: RXRX ) is one of the high-flying stocks gaining focus in today’s market. Indeed, shares of RXRX stock are rocketing more t...
InvestorPlace, 4 months agoCathie Wood just gave the company a huge vote of confidence.
The Motley Fool, 5 months ago